Healthcare -
Biotechnology - NASDAQ - US
$ 1.22
-1.61 %
$ 101 M
Market Cap
-0.48
P/E
EDIT - REVENUE
Revenue EDIT - Editas Medicine, Inc.
78.1 M
LAST VALUE
74.88%
2 YEAR CAGR
19.59%
5 YEAR CAGR
0.00%
10 YEAR CAGR